Literature DB >> 23937353

Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity?

R Farré1.   

Abstract

BACKGROUND: Gastro-esophageal reflux disease (GERD) is very prevalent and has a high burden on health security system costs. Nevertheless, pathophysiology is complex and not well-understood. Several mechanisms have been proposed: decreased salivation, impaired esophageal clearance, decreased lower esophageal sphincter pressure resting tone, presence of hiatal hernia, increased number of transient lower esophageal sphincter relaxations (TLESRs), increased acid, and pepsin secretion, pyloric incompetence provoking duodeno-gastro-esophageal reflux of bile acids and trypsin. Independent of the relevance of each mechanism, the ultimate phenomenon is that mucosal epithelium is exposed for a longer time to agents as acid and pepsin or is in contact to luminal agents not commonly present in gastric refluxate as trypsin or bile acids. This leads to a visible damage of the epithelium (erosive esophagitis -EE) or impairing mucosal integrity without any sign of macroscopic alteration as occurs in non-erosive reflux disease (NERD). Luminal factors are not the only responsible for such impairment; more recent data indicate that endogenous factors may also play a role.
PURPOSE: This review will update the most recent findings on the putative pathophysiological mechanisms and specially will focus on the role of esophageal mucosal integrity in GERD. Methodologies used for the evaluation of mucosal integrity, its relevance in EE and NERD, its involvement in symptoms perception and the effect of luminal and endogenous factors will be discussed.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  baseline impedance; gastro-esophageal reflux disease; luminal and endogenous factors; mucosal integrity; pathophysiology

Mesh:

Year:  2013        PMID: 23937353     DOI: 10.1111/nmo.12201

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  19 in total

1.  Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.

Authors:  Marzio Frazzoni; Nicola de Bortoli; Leonardo Frazzoni; Manuele Furnari; Irene Martinucci; Salvatore Tolone; Andrea Farioli; Santino Marchi; Lorenzo Fuccio; Vincenzo Savarino; Edoardo Savarino
Journal:  J Gastroenterol       Date:  2016-05-30       Impact factor: 7.527

2.  Determinants of reflux perception in patients with non-erosive reflux disease who have reflux-related symptoms on potassium-competitive acid blocker therapy.

Authors:  Noriyuki Kawami; Shintaro Hoshino; Yoshimasa Hoshikawa; Tomohide Tanabe; Mai Koeda; Eri Momma; Nana Takenouchi; Yuriko Hanada; Mitsuru Kaise; Katsuhiko Iwakiri
Journal:  Esophagus       Date:  2021-10-15       Impact factor: 4.230

3.  Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction.

Authors:  Kentaro Sugano; Stuart Jon Spechler; Emad M El-Omar; Kenneth E L McColl; Kaiyo Takubo; Takuji Gotoda; Mitsuhiro Fujishiro; Katsunori Iijima; Haruhiro Inoue; Takashi Kawai; Yoshikazu Kinoshita; Hiroto Miwa; Ken-Ichi Mukaisho; Kazunari Murakami; Yasuyuki Seto; Hisao Tajiri; Shobna Bhatia; Myung-Gyu Choi; Rebecca C Fitzgerald; Kwong Ming Fock; Khean-Lee Goh; Khek Yu Ho; Varocha Mahachai; Maria O'Donovan; Robert Odze; Richard Peek; Massimo Rugge; Prateek Sharma; Jose D Sollano; Michael Vieth; Justin Wu; Ming-Shiang Wu; Duowu Zou; Michio Kaminishi; Peter Malfertheiner
Journal:  Gut       Date:  2022-06-20       Impact factor: 31.793

4.  Protease-Activated Receptor-2 Up-Regulates Transient Receptor Potential Vanilloid 4 Function in Mouse Esophageal Keratinocyte.

Authors:  Nobuhiro Suzuki; Hiroshi Mihara; Hirofumi Nishizono; Makoto Tominaga; Toshiro Sugiyama
Journal:  Dig Dis Sci       Date:  2015-08-02       Impact factor: 3.199

5.  Electrical stimulation therapy for gastroesophageal reflux disease.

Authors:  Nicolaas F Rinsma; Nicole D Bouvy; Ad A M Masclee; José M Conchillo
Journal:  J Neurogastroenterol Motil       Date:  2014-07-31       Impact factor: 4.924

6.  Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease.

Authors:  Nicolaas F Rinsma; Ricard Farré; Fred J Troost; Montserrat Elizalde; Daniel Keszthelyi; Zsuzsanna Helyes; Ad A Masclee; José M Conchillo
Journal:  Int J Mol Sci       Date:  2017-05-19       Impact factor: 5.923

7.  Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.

Authors:  V Savarino; F Pace; C Scarpignato
Journal:  Aliment Pharmacol Ther       Date:  2017-01-24       Impact factor: 8.171

8.  Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union.

Authors:  Suzy Huijghebaert; Guido Vanham; Myriam Van Winckel; Karel Allegaert
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

9.  Increased Risk of Chronic Sinusitis in Adults With Gastroesophgeal Reflux Disease: A Nationwide Population-Based Cohort Study.

Authors:  Yu-Hsuan Lin; Ting-Shou Chang; Yi-Chien Yao; Ying-Chun Li
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

Review 10.  Drugs for improving esophageal mucosa defense: where are we now and where are we going?

Authors:  Edoardo Savarino; Patrizia Zentilin; Elisa Marabotto; Gaia Pellegatta; Claudia Coppo; Matteo Brunacci; Pietro Dulbecco; Vincenzo Savarino
Journal:  Ann Gastroenterol       Date:  2017-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.